For Healthcare Professionals: Liver Cancer

Over the past decade, Memorial Sloan Kettering has treated more than 5,000 patients with primary liver cancer. Our multidisciplinary liver cancer team has pursued numerous novel strategies to improve the non-surgical treatment of individuals with advanced or recurrent disease. For example, we led the first clinical trial that evaluated sorafenib, a novel biologic that stops liver cancer cells from replicating or targeting the blood vessels that nourish liver tumors.

Refering a Patient

Call 866-316-8529
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday, possible today.

Pictured: William Jarnagin
Liver Cancer Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of liver cancer in patient-friendly language

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Nancy Kemeny
Treating Liver Metastases with Hepatic Arterial Infusion Therapy

Medical oncologist Nancy Kemeny reviews evidence for HAI in extending survival and improving quality of life for patients with colorectal cancer and liver metastases.